Tarsus Pharmaceuticals (TARS)
(Delayed Data from NSDQ)
$37.00 USD
+2.96 (8.70%)
Updated May 10, 2024 04:00 PM ET
After-Market: $37.02 +0.02 (0.05%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -1.05 |
EPS Last Quarter | -1.01 |
Last EPS Surprise | 12.17% |
ABR | 1.22 |
Earnings ESP
|
5.42% |
---|---|
Current Year | -4.05 |
Next Year | -2.22 |
EPS (TTM) | -4.77 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 27.72M | 33.30M | 123.98M | 229.84M |
# of Estimates | 4 | 4 | 4 | 3 |
High Estimate | 33.59M | 42.13M | 154.32M | 281.01M |
Low Estimate | 22.10M | 25.40M | 95.60M | 182.00M |
Year ago Sales | 0.00M | 1.87M | 17.45M | 123.98M |
Year over Year Growth Est. | NA | 1,680.86% | 610.59% | 85.39% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.05 | -1.02 | -4.05 | -2.22 |
# of Estimates | 6 | 4 | 5 | 4 |
Most Recent Consensus | -1.08 | -1.02 | -3.97 | -1.85 |
High Estimate | -0.83 | -0.76 | -3.41 | -1.54 |
Low Estimate | -1.24 | -1.26 | -4.93 | -3.57 |
Year ago EPS | -1.17 | -1.28 | -4.62 | -4.05 |
Year over Year Growth Est. | 10.26% | 20.31% | 12.34% | 45.30% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 2 | 2 | 1 | 1 |
Up Last 30 Days | 2 | 2 | 2 | 2 |
Up Last 60 Days | 2 | 2 | 3 | 3 |
Down Last 7 Days | 0 | 0 | 2 | 1 |
Down Last 30 Days | 0 | 0 | 1 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.05 | -1.02 | -4.05 | -2.22 |
7 Days Ago | -1.24 | -1.21 | -4.25 | -2.16 |
30 Days Ago | -1.24 | -1.21 | -4.59 | -2.62 |
60 Days Ago | -1.24 | -1.19 | -4.61 | -2.84 |
90 Days Ago | -1.48 | -1.38 | -4.93 | -2.64 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.99 | -0.90 | -3.66 | -1.82 |
Zacks Consensus Estimate | -1.05 | -1.02 | -4.05 | -2.22 |
Earnings ESP | 5.42% | 11.77% | 9.67% | 17.93% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.01 | -1.31 | -1.28 | -1.17 | NA |
Estimate | -1.15 | -1.37 | -1.40 | -1.08 | NA |
Difference | 0.14 | 0.06 | 0.12 | -0.09 | 0.06 |
Surprise | 12.17% | 4.38% | 8.57% | -8.33% | 4.20% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more